Skip to content

Effectiveness Of Homoeopathic Medicines In Reducing the Severity Of Patients Suffering From Atopic Dermatitis

Effectiveness Of Individualized Homoeopathic Medicines In Reducing the Severity Of Patients Suffering From Atopic Dermatitis Using Kents Repertory: A Single Group, Pre-Post Interventional study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044165
Enrollment
50
Registered
2022-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine: Medicine Prescribed on the basis of the Totality of symptoms of the patient that is the whole constitution of the patient i.e the patient as a whol

Sponsors

Dr Aditi Vengurlekar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient Aged 18-65 years of both sexes 2. Presence of Features of Eczematous Dermatitis (erythema, exudation, lichenification, scales and crusts, papules, vesicles) for minimum of 6 months 3. Presence of Eczematous lesions especially on flexural surfaces but may have low grade involvement of any part of body. 4. Presence of Pruritis for minimum of 6 months 5. Patients giving written consent and complying with study procedures

Exclusion criteria

Exclusion criteria: 1.Cases of Eczema with a definite history of exposure to an irritant or allergen 2.Patients who do not comply with termination of application of External ointments for the eczematous lesions 3.Undertaking homoeopathic treatment for any other chronic disease or currently receiving treatment for Atopic dermatitis from any system of medicine 4.Erythema because of any other cause 5.Diagnosed cases of unstable psychiatric complaints 6.Any diagnosed systemic diseases affecting the quality of life 7.Pregnant and lactating women 8.Patients with immunocompromised conditions 9.Illiterate Patients who are unable to give written consent and fill in the assessment score

Design outcomes

Primary

MeasureTime frame
Scoring of Atopic Dermatitis (SCORAD) IndexTimepoint: At Baseline and After 3 months of intervention

Secondary

MeasureTime frame
Outcome Related Impact on Daily Living (ORIDL) ScoreTimepoint: At Baseline and after 3 Months of intervention

Countries

India

Contacts

Public ContactDr Pradip Kumar Bairi

Mahesh Bhattacharyya Homoeopathic Medical College and Hospital

drpkbairi@gmail.com9433122932

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026